Understanding the role and molecular mechanisms of AQP4+EVs could provide novel therapeutic targets, particularly for treatments aimed at restoring blood-brain barrier (BBB) integrity in bipolar disorder. This evidence concerns the gene AQP4 and bipolar disorder.